hers - Search News

News

Hims & Hers CEO No Longer A Billionaire

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

Hims & Hers CEO No Longer A Billionaire After Novo Nordisk Deal Collapses

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more than $400 million on Monday.

The Motley Fool on MSN · 2d

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

9hon MSN

Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity?

Novo Nordisk (NYSE: NVO) severed its partnership with Hims & Hers (NYSE: HIMS), arguing that the company breached the ...

3hon MSN

Stocks on the Move: Hims & Hers Health and JetBlue

The Investment Committee discuss their strategy on some stocks on the move today. California Democrats stage internal war ...

3don MSN

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

1d

Hims & Hers: Panic Sell Or Opportunistic Buy?

The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here for a full investment ...

2don MSN

These Stocks Are Moving the Most Today: Tesla, Hims & Hers, Wolfspeed, Super Micro, Fiserv, Northrop, Northern Trust, and More

Stocks were rising Monday, shrugging off Iran’s attack on a U.S. base in Qatar after the U.S. struck Iranian nuclear sites ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results